Chronic lymphocytic leukaemia is driven by antigen-independent cell-autonomous signalling

Nature

Volumn 489, Issue 7415, 2012, Pages 309-312

  Minden, Marcus Dühren Von ^a   Übelhart, Rudolf ^a   Schneider, Dunja ^a   Wossning, Thomas ^a   Bach, Martina P ^a   Buchner, Maike ^b   Hofmann, Daniel ^a   Surova, Elena ^a   Follo, Marie ^b   Köhler, Fabian ^a   Wardemann, Hedda ^c   Zirlik, Katja ^b   Veelken, Hendrik ^d   Jumaa, Hassan ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c MAX PLANCK INSTITUTE FOR INFECTION BIOLOGY   (Germany)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

B CELL ANTIGEN RECEPTOR; EPITOPE; RECEPTOR; UNCLASSIFIED DRUG;

ANTIGEN; BLOOD SYSTEM DISORDER; CANCER; GENE EXPRESSION; MOLECULAR ANALYSIS; NUMERICAL MODEL; PATHOGENICITY; TUMOR;

ANIMAL CELL; ARTICLE; CHRONIC LYMPHATIC LEUKEMIA; COMPLEMENTARITY DETERMINING REGION; CONTROLLED STUDY; HEAVY CHAIN COMPLEMENTARITY DETERMINING REGION; MOUSE; MUTATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BINDING; SIGNAL TRANSDUCTION;

AMINO ACID MOTIFS; AUTOANTIGENS; CALCIUM SIGNALING; COMPLEMENTARITY DETERMINING REGIONS; EPITOPES, B-LYMPHOCYTE; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; RECEPTORS, ANTIGEN, B-CELL; SIGNAL TRANSDUCTION;

EID: 84866152172     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature11309     Document Type: Article

References (28)

1. Morton, L. M. et al. Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. Blood 107, 265-276 (2006).
2. Ghiotto, F. et al. Remarkably similar antigen receptors among a subset of patients with chronic lymphocytic leukemia. J. Clin. Invest. 113, 1008-1016 (2004).
3. Stamatopoulos, K. et al. Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: pathogenetic implications and clinical correlations. Blood 109, 259-270 (2007).
4. Bikos, V. et al. Over 30%of patients with splenicmarginal zone lymphomaexpress the same immunoglobulin heavy variable gene: ontogenetic implications. Leukemia 26, 1638-1646 (2012).
5. Widhopf, G. F. II et al. Chronic lymphocytic leukemia B cells of more than 1% of patients express virtually identical immunoglobulins. Blood 104, 2499-2504 (2004).
6. Ghia, P., Chiorazzi, N. & Stamatopoulos, K. Microenvironmental influences in chronic lymphocytic leukaemia: the role of antigen stimulation. J. Intern. Med. 264, 549-562 (2008).
7. Stevenson, F. K., Krysov, S., Davies, A. J., Steele, A. J. & Packham, G. B-cell receptor signaling in chronic lymphocytic leukemia. Blood 118, 4313-4320 (2011).
8. Köhler, F. et al.AutoreactiveBcell receptorsmimicautonomous pre-Bcell receptor signaling and induce proliferation of early B cells. Immunity 29, 912-921 (2008).
9. Ü belhart, R. et al. N-linked glycosylation selectively regulates autonomous precursor BCR function. Nature Immunol. 11, 759-765 (2010).
10. Hervé, M. et al. Unmutated and mutated chronic lymphocytic leukemias derive from self-reactive B cell precursors despite expressing different antibody reactivity. J. Clin. Invest. 115, 1636-1643 (2005).
11. Sthoeger, Z. M. et al. Production of autoantibodies by CD5-expressing B lymphocytes from patients with chronic lymphocytic leukemia. J. Exp. Med. 169, 255-268 (1989).
12. Meixlsperger, S. et al. Conventional light chains inhibit the autonomous signaling capacity of the B cell receptor. Immunity 26, 323-333 (2007).
13. Bichi, R. et al. Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression. Proc. Natl Acad. Sci. USA 99, 6955-6960 (2002).
14. Herling, M. et al. High TCL1 levels are a marker of B-cell receptor pathway responsiveness and adverse outcome in chronic lymphocytic leukemia. Blood 114, 4675-4686 (2009).
15. Yan, X. J. et al. B cell receptors in TCL1 transgenic mice resemble those of aggressive, treatment-resistant human chronic lymphocytic leukemia. Proc. Natl Acad. Sci. USA 103, 11713-11718 (2006).
16. Binder, M. et al. B-cell receptor epitope recognition correlates with the clinical course of chronic lymphocytic leukemia. Cancer 117, 1891-1900 (2011).
17. Kulathu, Y., Grothe, G. & Reth, M. Autoinhibition and adapter function of Syk. Immunol. Rev. 232, 286-299 (2009).
18. Herishanu, Y. et al. The lymph node microenvironment promotes B-cell receptor signaling, NF-kB activation, and tumor proliferation in chronic lymphocytic leukemia. Blood 117, 563-574 (2011).
19. Seiler, T. et al. Characterization of structurally defined epitopes recognized by monoclonal antibodies produced by chronic lymphocytic leukemia B cells. Blood 114, 3615-3624 (2009).
20. Buchner, M. et al. Spleen tyrosine kinase inhibition prevents chemokine-and integrin-mediated stromal protective effects in chronic lymphocytic leukemia. Blood 115, 4497-4506 (2010).
21. Suljagic, M. et al. The Syk inhibitor fostamatinib disodium (R788) inhibits tumor growth in the Em-TCL1 transgenic mouse model of CLL by blocking antigendependent B-cell receptor signaling. Blood 116, 4894-4905 (2010).
22. Friedberg, J. W. et al. Inhibition of Syk with fostamatinib disodium has significant clinical activity in non-Hodgkin lymphoma and chronic lymphocytic leukemia. Blood 115, 2578-2585 (2010)
23. Wardemann, H. et al. Predominant autoantibody production by early human B cell precursors. Science 301, 1374-1377 (2003).
24. Tiller, T. et al. Development of self-reactive germinal center B cells and plasma cells in autoimmune FccRIIB-deficient mice. J. Exp. Med. 207, 2767-2778 (2010).
25. Bertinetti, C. et al. Cloning of idiotype immunoglobulin genes in B cell lymphomas by anchored PCR and production of individual recombinant idiotype vaccines in Escherichia coli. Eur. J. Haematol. 77, 395-402 (2006).
26. Osterroth, F. et al. Rapid expression cloning of human immunoglobulin Fab fragments for the analysis of antigen specificity of B cell lymphomas and antiidiotype lymphoma vaccination. J. Immunol. Methods 229, 141-153 (1999).
27. Su, Y. W. & Jumaa, H. LAT links the Pre-BCR to calcium signaling. Immunity 19, 295-305 (2003).
28. Storch, B., Meixlsperger, S. & Jumaa, H. The Ig-a ITAM is required for efficient differentiation but not proliferation of pre-B cells. Eur. J. Immunol. 37, 252-260 (2007).